Zobrazeno 1 - 10
of 1 023
pro vyhledávání: '"Aj, Scheen"'
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 15:250-254
Resume L'exploration d'un sujet obese vise a mieux comprendre la maladie, ses causes et ses consequences, de facon a optimaliser la prise en charge. Sur le plan biologique, il convient de rechercher une eventuelle etiologie endocrinienne a l'obesite
Publikováno v:
Vrije Universiteit Brussel
Type 1 diabetes is characterized by the autoimmune-mediated destruction of the insulin-producing beta cells of the pancreatic islets of Langerhans. Several cells are potentially implicated in the selective destruction of beta cells, including the bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ed40a19e64d2b567ec8ddd9a611dc53b
https://biblio.vub.ac.be/vubir/monoclonal-antibodies-in-diabetes-almost-approaching-the-dream(21fd9ea3-33ba-4415-abf7-b08bb1390af2).html
https://biblio.vub.ac.be/vubir/monoclonal-antibodies-in-diabetes-almost-approaching-the-dream(21fd9ea3-33ba-4415-abf7-b08bb1390af2).html
Autor:
AJ Scheen
Publikováno v:
Inpharma Weekly. :19-20
Autor:
Schrouff I, Valdes-Socin H, Frippiat F, Laurence de Leval, Soyeur D, Ma, Radermecker, Aj, Scheen
Publikováno v:
Europe PubMed Central
Isolated tricuspid valve endocarditis is the least common endocarditis with an incidence of 5 to 10% in the literature. It is usually described in drug abusers and as a complication of nosocomial infections (catheter, post-surgery...). We present the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a4e0c39f21d3477a6306b56e16d80577
http://europepmc.org/abstract/med/18217640
http://europepmc.org/abstract/med/18217640
Autor:
Scheen AJ; Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, B-4000 Liège, Belgium; Division of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium. Electronic address: andre.scheen@chuliege.be.
Publikováno v:
The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2024 Oct; Vol. 12 (10), pp. 685-687. Date of Electronic Publication: 2024 Sep 06.
Autor:
Scheen AJ; Division of Diabetes, Nutrition and Metabolic Disorders, CHU Liège, Liège, Belgium. andre.scheen@chuliege.be.; Division of Clinical Pharmacology, Centre for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium. andre.scheen@chuliege.be.
Publikováno v:
Drugs [Drugs] 2024 Sep 28. Date of Electronic Publication: 2024 Sep 28.
Autor:
Scheen AJ; Professeur honoraire, Service de diabétologie, nutrition et maladies métaboliques, Département de médecine, Centre hospitalier universitaire de Liège, 4000 Liège, Belgique.
Publikováno v:
Revue medicale suisse [Rev Med Suisse] 2024 Aug 28; Vol. 20 (884), pp. 1498-1502.
Autor:
Scheen AJ; Service de diabétologie, nutrition et maladies métaboliques, Département de médecine, Centre hospitalier universitaire de Liège, 4000 Liège, Belgique., Paquot N; Service de diabétologie, nutrition et maladies métaboliques, Département de médecine, Centre hospitalier universitaire de Liège, 4000 Liège, Belgique.
Publikováno v:
Revue medicale suisse [Rev Med Suisse] 2024 Aug 28; Vol. 20 (884), pp. 1492-1497.
Autor:
Scheen AJ; Service de diabétologie, nutrition et maladies métaboliques et Unité de pharmacologie clinique CHU de Liège, Belgique.
Publikováno v:
Revue medicale suisse [Rev Med Suisse] 2024 Aug 28; Vol. 20 (884), pp. 1485-1486.
Autor:
Scheen AJ; Division of Diabetes, Nutrition and Metabolic Disorders, CHU Liège, Liège, Belgium.; Division of Clinical Pharmacology, Centre for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium.
Publikováno v:
Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Jul; Vol. 23 (7), pp. 797-810. Date of Electronic Publication: 2024 May 13.